Latest News
Charles River Forges Strategic Partnership with Bit Bio, Increasing Portfolio of Translational Drug Discovery Technologies
12 December 2019 - - US-based Charles River Laboratories International, Inc. (NYSE: CRL) has entered into an exclusive Discovery and Safety Services partnership with Bit Bio, a company that offers consistent and efficient reprogramming of human ...
US Patent Issued for Method of Generating Induced Pluripotent Stem Cells
12 December 2019 - - The United States Patent and Trademark Office (USPTO) has issued US Patent No. 10,501,723, entitled "Methods of Reprogramming Animal Somatic Cells" covering what is commonly designated "induced Pluripotent Stem cel...
Moderna Names Nader to Board of Directors
12 December 2019 - - Former CEO of NPS Pharmaceuticals brings broad expertise to support Moderna's progress towards late-stage development and commercialization

US-based clinical stage biotechnology company Moderna, Inc., (NASDAQ: M...
Leo Pharma Joins Certara's PBPK Simcyp Simulator Consortium
12 December 2019 - - Danish pharmaceutical company Leo Pharma has licensed US-based model-informed drug development and decision support Certara's proprietary Simcyp Population-based Simulator and joined its consortium, Certara said.

DarzalexRegimen Shows Significant Increase in Progression-Free Survival in Treatment of Patients with Relapsed/Refractory Multiple Myeloma
12 December 2019 - - US-based healthcare company Johnson and Johnson's (NYSE: JNJ) The Janssen Pharmaceutical Companies business has received results from the Phase 3 CANDOR study showing that the addition of Darzalex (daratumumab) to carfi...